NCT06144619

Non-Invasive Biomarkers in Prostate Cancer Disease Management

• Status: Suspended
• Phase: —
• Study type: Observational
• Enrollment: 500 (estimated)
• Sponsor: H. Lee Moffitt Cancer Center and Research Institute · Academic / Other
• Sex: Male
• Age: 35 Years – 85 Years
• Healthy volunteers: Not accepted

Summary

This study is an observational retrospective/ prospective study with diagnosed low/intermediate risk (no-surgery) \& high risk (surgery) prostate cancer that are eligible and willing to undergo standard of care (SOC) assessment, annually along with biopsies, bio-fluid collection. Participants will obtain genomic and histological evaluation on their biopsied samples. Study follows SOC collection with additional body fluid collection (blood, urine). Biopsy/surgery will not require additional sample collection

Conditions

• Prostate Cancer

Interventions

Type	Name	Description
GENETIC	Genomic and Histological Evaluation	Participants will obtain genomic and histological evaluation on their biopsied samples. (Follows SOC)

Timeline

• Start date: 2023-11-21
• Primary completion: 2029-01-31
• Completion: 2029-01-31
• First posted: 2023-11-22
• Last updated: 2026-02-09

Locations

1 site across 1 country: United States